Canada’s Blind Spot on Drug Safety in Pregnancy – SOGC
The Society of Obstetricians and Gynaecologists of Canada (SOGC) shared a post on LinkedIn:
“A new op-ed published in the Montreal Gazette, co-authored by SOGC CEO Dr. Diane Francoeur and SOGC member Prof. Anick Bérard, highlights a critical gap in women’s health: the lack of robust data on the safety of medications during pregnancy.
Dr. Francoeur and Prof. Bérard note that most prescription drugs approved in Canada lack adequate safety data for use in pregnancy, leaving patients and physicians to make important decisions without clear evidence.
They call for stronger national data infrastructure, sustained investment in women’s health research and better integration of real-world evidence to change behaviour and improve outcomes.
Read the full op-ed.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 9, 2026, 18:30Christopher Robinson: The Nausicaä Suture in the Management of the Placenta Accreta Spectrum
-
Jun 9, 2026, 18:28Ronald Feinberg: Bridging the Gap Between Fertility and Menopause Care
-
Jun 9, 2026, 18:26Hala El Damanhoury: The Right Questions Shape Better Birth Experiences
-
Jun 9, 2026, 18:25Call for Reviewers, AI in Gynecologic Cancer Literature – IJGC
-
Jun 9, 2026, 18:21Julie Morgan: How Generative AI Is Reshaping Fertility Care?
-
Jun 9, 2026, 18:19Simone Ferrero: The Diagnosis of Endometriosis, From Vision to Publication
-
Jun 9, 2026, 18:17Scammers Are Targeting ESHRE2026 Attendees With Fake Registration and Hotel Offers! – ESHRE
-
Jun 9, 2026, 18:15Diagnostic Challenge, Looking Beyond Renal Duplication and Ureterocele! – CFEF
-
Jun 9, 2026, 18:13Christopher Robinson: Trends in Antenatal Corticosteroid Use in Late Preterm Multiple Gestations